Vaishalee Kenkre, MD, Walter Longo, MD

Articles by Vaishalee Kenkre, MD, Walter Longo, MD

Novel T-Cell Engineering Strategy Aims to Reduce GVHD in Lymphoma Transplantations

ByVaishalee Kenkre, MD, Walter Longo, MD,Peiman Hematti, MD

June 14th 2016

This pilot trial is the first of its type to investigate T cell receptor alpha/beta-depleted and CD19-depleted haploidentical stem cell grafts in relapsed/refractory lymphoma patients.

Latest Updated Articles

Novel T-Cell Engineering Strategy Aims to Reduce GVHD in Lymphoma Transplantations
June 14th 2016

Vaishalee Kenkre, MD, Walter Longo, MD

Articles by Vaishalee Kenkre, MD, Walter Longo, MD

Novel T-Cell Engineering Strategy Aims to Reduce GVHD in Lymphoma Transplantations

Latest Updated Articles

Trending on OncLive

Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg

HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA

Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL

Dato-DXd Hits Key Secondary Efficacy End Points in First-Line TNBC

Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis